StudyRareStudyRare

Mitochondrial trifunctional protein deficiency (TFP)

Log in to star

Last updated Nov 15, 2026

Log in to add personal notes on this page.

A child presents with cardiomyopathy, peripheral neuropathy, and pigmentary retinopathy. Acylcarnitine profile shows elevated long-chain hydroxy-acylcarnitines (C16-OH, C18-OH). The mother had HELLP syndrome during pregnancy.

AR; HADHA (alpha subunit) or HADHB (beta subunit) of mitochondrial trifunctional protein. Biallelic loss-of-function variants remove all three of the protein's enzyme activities.

Mitochondrial trifunctional protein (TFP) performs the last three steps of each turn of long-chain beta-oxidation. It is an octamer of four alpha subunits (HADHA), which carry long-chain enoyl-CoA hydratase and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD), and four beta subunits (HADHB), which carry long-chain 3-ketoacyl-CoA thiolase. In TFP deficiency all three activities are lost; in isolated LCHAD deficiency only the dehydrogenase is lost, and an enzyme assay separates the two.

Long-chain fat then yields no acetyl-CoA, so fasting or illness brings hypoketotic hypoglycemia, with cardiomyopathy, liver dysfunction, and skeletal myopathy. TFP also binds respiratory chain complex I and its alpha subunit remodels cardiolipin, which may explain the features shared with mitochondrial disease (lactic acidosis, polyneuropathy, retinopathy).

  • Variants in HADHA: about half of affected people have a severe or lethal course.
  • Variants in HADHB: 70% have a milder course; a missense variant on at least one allele favors the milder phenotype, while truncating and frameshift variants give the severe one.

Compared with isolated LCHAD deficiency, TFP deficiency more often presents as severe neonatal disease (39% vs 15%), also has a mild neuromyopathic form that is rare in LCHAD deficiency, and less often causes retinopathy (12% vs 80%).

very long-chain acyl-CoAdehydrogenaseACADVL; electrons to FADVLCAD deficiencyhydratase, trifunctional proteinalpha subunitHADHAtrifunctional protein deficiencylong-chain 3-hydroxyacyl-CoAdehydrogenase, alpha subunitHADHALCHAD deficiencytrifunctional protein deficiencythiolase, trifunctional proteinbeta subunitHADHBtrifunctional protein deficiencyeach turn shortens the chain bytwo carbonslong-chain acyl-CoA(14 to 20 carbons)long-chain enoyl-CoA3-hydroxyacyl-CoA3-ketoacyl-CoAacetyl-CoA + acyl-CoAtwo carbons shortermedium-chain acyl-CoA(6 to 10 carbons)
Excerpt from fatty acid beta-oxidation. See the full pathway.

Part of fatty acid beta-oxidation.

Mitochondrial fatty acid beta-oxidation, the last three steps of each long-chain turn.

long-chain acyl-CoA → VLCAD → enoyl-CoA → trifunctional protein: hydratase → 3-hydroxyacyl-CoA → LCHAD → 3-ketoacyl-CoA → thiolase (the block, all three steps) → acetyl-CoA plus an acyl-CoA two carbons shorter → ketone bodies and Krebs cycle

  • Accumulates: long-chain 3-hydroxyacyl intermediates, measured as C16-OH with C18-OH and C18:1-OH (the same profile as isolated LCHAD deficiency); urine 3-hydroxy-dicarboxylic acids.
  • Missing: acetyl-CoA from long-chain fat, so fasting brings hypoketotic hypoglycemia and energy failure in heart and muscle.
  • Workbook: 5.I. LCHAD deficiency
  • Phenotype overlaps LCHAD: cardiomyopathy, hepatopathy, rhabdomyolysis, peripheral neuropathy, pigmentary retinopathy
  • TFP deficiency more often presents as severe neonatal disease than isolated LCHAD deficiency (39% vs 15%), but its range also extends to a mild neuromyopathic form that is rare in LCHAD deficiency; retinopathy is much less common (12% vs 80%)
  • Maternal HELLP and acute fatty liver of pregnancy (AFLP) are characteristic when the fetus is affected; the mother is an obligate heterozygote
  • Same NBS biomarker as LCHAD: C16-OH (with C14-OH, C18-OH)
  • On RUSP
  • Detected on newborn screening: elevated C16-OH, with C14-OH and C18-OH long-chain hydroxyacylcarnitines (same profile as isolated LCHAD)
  • Confirmation: HADHA/HADHB molecular testing; trifunctional protein enzyme assay distinguishes complete TFP (all three activities lost) from isolated LCHAD
  • Hypoketotic hypoglycemia during catabolic stress
  • Avoid fasting; emergency IV glucose during illness
  • Low long-chain-fat diet with MCT supplementation
  • Triheptanoin (an odd-chain triglyceride) is approved for long-chain FAO disorders and improves cardiac and metabolic outcomes
  • Surveillance for retinopathy, neuropathy, and cardiomyopathy

LCHAD is one leg of the TFP stool. LCHAD = the dehydrogenase activity only; TFP = all three activities. Same biomarker (C16-OH), broader enzyme loss, more severe neonatal disease.

Maternal HELLP or AFLP in a heterozygous mother carrying an affected fetus is the classic pregnancy clue for TFP or LCHAD. The fetal liver cannot oxidize long-chain fats, and toxic intermediates cross into the maternal circulation.

Reference Links